The following are press releases about our post transplant skin cancer research initiative.
Pain drug and chemo-VNR
One of the most popular ways to treat skin cancer could be made much more effective simply by adding celecoxib, a member of a growing class of pain relievers known as non-steroidal anti-inflammatory drugs, or NSAIDS. Read more... Sun-safe strategies-VNR
Skin cancer experts at the Ohio State University Comprehensive Cancer Center-Arthur G. James Cancer Hospital and Richard J. Solove Research Institute are investigating multiple new strategies to prevent and treat melanoma and other skin cancers, but they say the most effective strategy is to avoid unnecessary exposure to the sun and eliminate recreational tanning altogether. Read more...
Pain drug post-sunburn cancer prevention
A popular drug used for pain and arthritis also cuts in half the number of pre-cancerous skin lesions that occur through regular exposure to sunlight. The research, conducted at The Ohio State University Comprehensive Cancer Center (OSUCCC), raises the possibility of the first topical anti-cancer cream that could be used after a person becomes sunburned. Read more... Skin Cancer in Transplant Patients
Researchers have identified a key component of the immune system that helps transplant patients combat skin cancer, a growing problem with sometimes deadly consequences. Read more
|
